Sunshine Heart (NSDQ:SSH) said today it is looking at therapeutic strategies focused on neuromodulation rather than counterpulsation, touting the shift as a more cost effective strategy with a faster path to commercialization for its C-Pulse system. The C-Pulse system is designed to use intra-aortic balloon counter-pulsation to reduce the load on the left ventricle, using a cuff around the exterior […]
Sunshine Heart Inc.
Sunshine Heart pares losses, preps for 1st-in-human trial for C-Pulse heart failure device
Sunshine Heart (NSDQ:SSH) shares are gaining after the medical device company said today that it slashed its 1st-quarter losses, topping Wall Street’s expectation. Eden Prairie, Minn.-based Sunshine, which has not commercialized its C-Pulse heart failure device yet, cut its losses by -32.1% to -$4.8 million, or -26¢ per share; adjusted to exclude 1-time items, earnings per […]
Sunshine Heart halts trial, ousts CEO Rosa
Sunshine Heart (NSDQ:SSH) said today that it replaced CEO David Rosa with John Erb and halted a pair of clinical trials of its C-Pulse heart failure device. The C-Pulse system is designed to use intra-aortic balloon counter-pulsation to reduce the load on the left ventricle. Today the company said it’s stopping enrollment in its Counter-HF trial and Options-HF […]
Ivenix taps ex-GI Dynamics chief Randle for CEO | Personnel Moves
Ivenix said in named former GI Dynamics (ASX:GID) chief Stuart Randle to be its new CEO. Randle departed GI Dynamics in August 2014, after 10 years with the bariatric device maker. Amesbury, Mass.-based Ivenix, which raised $42 million last September, is developing an infusion management system for hospitals that will combine an information technology interface […]